Cargando…
The safety and effectiveness of high-calorie therapy for treating amyotrophic lateral sclerosis: a systematic review and meta-analysis
BACKGROUND: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder affecting the upper and lower motor neurons, which can lead to death from respiratory failure within 3–5 years after the onset of this disease. Nowadays, no drug can effectively slow down the progression of this disease....
Autores principales: | Zhu, Qiaochu, Xu, Dandan, Huang, Hai, Li, Dong, Yang, Dan, Zhou, Jing, Zhao, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511594/ https://www.ncbi.nlm.nih.gov/pubmed/37369861 http://dx.doi.org/10.1007/s00415-023-11838-4 |
Ejemplares similares
-
Risk factors associated with amyotrophic lateral sclerosis based on the observational study: a systematic review and meta-analysis
por: Zhu, Qiaochu, et al.
Publicado: (2023) -
Patient, carer and healthcare professional perspectives on increasing calorie intake in Amyotrophic Lateral Sclerosis
por: Coates, Elizabeth, et al.
Publicado: (2021) -
Current Therapy of Drugs in Amyotrophic Lateral Sclerosis
por: Lu, Haiyan, et al.
Publicado: (2016) -
Gene Therapy in Amyotrophic Lateral Sclerosis
por: Fang, Ton, et al.
Publicado: (2022) -
Safety and efficacy of edaravone in patients with amyotrophic lateral sclerosis: a systematic review and meta-analysis
por: Nourelden, Anas Zakarya, et al.
Publicado: (2023)